Please assess the completion status of the following clinical trial:

Trial Title: Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years ≤age ≤80 years~* The patient must be scheduled to undergo segmentectomy or combined subsegmentectomy.~* The patient must be willing and able to comply with all study requirements and have understood and signed the informed consent.~Exclusion Criteria:~* A known allergy to Iron Sucrose Injection~* The patients who have Iron overdose or iron utilization barrier Intra-operative founding of extensive pigmentation Silicosis or extensive carbon deposition in the lung.~* Patients who have not received segmental resection.~* Patients who converted to thoracotomy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Iron Sucrose injection group (Type: EXPERIMENTAL): The investigators inject Iron Sucrose (100 mg dissolved in 50 mL saline) through a butterfly needle into the bronchus of the targeting segment.

Based on this trial design, predict the completion outcome and termination type (if applicable).